-The Hindu Brazil, Mexico and Thailand have done it. Many countries with a sound understanding of development look at Universal Health Coverage as a vital requirement to achieve it. India is at a crossroads. Introducing UHC in the 12th Plan can transform the lives of Indians, create new jobs and galvanise the economy. Most people would agree that one’s income or caste or gender should not bar one’s ability to get decent...

-The Indian Express At a time when the government is struggling to get past objections from its coalition partners to attract investment in certain sectors such as retail, aviation and pensions fund management, a grim internecine ministerial battle has applied the brakes on foreign direct investment flow into one of the more attractive and lucrative sectors — pharmaceuticals. Clearances for over Rs 1,000 crore FDI in this sector, the second largest in...

-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...

-The Times of India Some good news for consumers might be at hand. You would soon be able to find the most affordable alternative to the medicine prescribed by your doctor through an SMS-based service. The service, expected to be launched by the government in August, will be available throughout the country. Here is how it works: Once the person sends a text message of the prescribed brand of drug to a...

Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines. ACTA, primarily drafted and secretly negotiated by the US, was signed on October...